Castle Biosciences, Inc. (CSTL)
NASDAQ: CSTL · Real-Time Price · USD
24.30
+1.39 (6.07%)
At close: Jun 26, 2026, 4:00 PM EDT
24.50
+0.20 (0.82%)
After-hours: Jun 26, 2026, 7:51 PM EDT
Castle Biosciences Employees
Castle Biosciences had 942 employees as of March 31, 2026. The number of employees increased by 59 or 6.68% since the number was last reported on December 31, 2025.
Employees
942
Change
59
Growth
6.68%
Revenue / Employee
$360,849
Profits / Employee
-$13,622
Market Cap
737.02M
Employees Chart
Related Stocks
| Company Name | Employees |
|---|---|
| Myriad Genetics | 2,700 |
| NeoGenomics | 2,500 |
| OPKO Health | 2,275 |
| Fulgent Genetics | 1,315 |
| GeneDx Holdings | 1,300 |
| GRAIL | 910 |
| CareDx | 765 |
| Adaptive Biotechnologies | 624 |
CSTL News
- 3 days ago - Castle Biosciences’ i31-SLNB outperforms MIA nomogram in lymph node biopsy - TheFly
- 3 days ago - DecisionDx®-Melanoma's i31-SLNB Outperforms MIA Nomogram in Identifying Patients Who May Safely Forgo Sentinel Lymph Node Biopsy - PRNewsWire
- 3 days ago - Roth starts Castle Biosciences at Buy, notes quality revenue growth outlook - TheFly
- 4 days ago - Castle Biosciences initiated with a Buy at Roth Capital - TheFly
- 5 days ago - Castle Biosciences' Chief Financial Officer Frank Stokes Named a 2026 CFO Awards Honoree by the Houston Business Journal - PRNewsWire
- 9 days ago - Castle Biosciences Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - PRNewsWire
- 12 days ago - Castle Biosciences’ TissueCypher Test surpasses 100,000 orders - TheFly
- 18 days ago - First Patient Enrolled in New Study Assessing early prediction of flares in Atopic Dermatitis by Castle Biosciences in Collaboration with SciBase - PRNewsWire